Pacer Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
PCM
DKCM
AAM
TAL
UOC
Pacer Advisors's AMED Position: Q1 2025 in Review
Pacer Advisors sold out of Amedisys (AMED) in Q1 2025, closing a stake of 558,197 shares — an estimated $50.7M sold.
Pacer Advisors first reported a position in AMED in Q2 2019 and held it in 20 quarters. The position peaked at $50.7M in Q4 2024. 304 funds tracked by Wall St. Rank hold AMED as of Q1 2025.
- Pacer Advisors reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
- Pacer Advisors sold 558,197 Amedisys shares in Q1 2025, an estimated $50.7M.
- Pacer Advisors first reported a position in Amedisys in Q2 2019 and held it in 20 quarters.
- Pacer Advisors's Amedisys position peaked at $50.7M in Q4 2024.
- 304 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.
Based on Pacer Advisors's 13F filing for Q1 2025, filed 6 May 2025.